Key Insights

Highlights

Success Rate

95% trial completion (above average)

Published Results

17 trials with published results (13%)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 27/100

Termination Rate

1.6%

2 terminated out of 129 trials

Success Rate

94.9%

+8.3% vs benchmark

Late-Stage Pipeline

10%

13 trials in Phase 3/4

Results Transparency

46%

17 of 37 completed with results

Key Signals

17 with results95% success

Data Visualizations

Phase Distribution

104Total
Not Applicable (53)
Early P 1 (5)
P 1 (23)
P 2 (10)
P 3 (12)
P 4 (1)

Trial Status

Recruiting51
Completed37
Not Yet Recruiting27
Active Not Recruiting5
Enrolling By Invitation4
Withdrawn2

Trial Success Rate

94.9%

Benchmark: 86.6%

Based on 37 completed trials

Clinical Trials (129)

Showing 20 of 20 trials
NCT07610369Phase 2Recruiting

The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease

NCT07839481Not ApplicableNot Yet RecruitingPrimary

Effects of Transcutaneous Cervical Vagus Nerve Stimulation on Non-motor Symptoms in Parkinson's Disease

NCT07464028Phase 2SuspendedPrimary

Terazosin And Metabolic Energetics in Parkinson's Disease

NCT07835230Not ApplicableCompletedPrimary

Boxing-Based Training to Improve Balance and Mobility in Parkinson's Disease

NCT07284784Phase 2RecruitingPrimary

A Study of Buntanetap in Participants With PD

NCT07830654Phase 2RecruitingPrimary

This Protocol is a Sub-study Under the PPMI Program. It is a Longitudinal, Single-center Study to Assess the Performance of [18F]AV-133 Imaging Using High and Standard Resolution PET in Individuals Enrolled With Parkinson's Disease (PD) for up to 12 Months.

NCT07831980Not ApplicableNot Yet RecruitingPrimary

Blood Flow Restriction Aerobic Exercise for Balance and Anxiety in Parkinson's Disease

NCT07820189Not ApplicableNot Yet Recruiting

Effects of Microelectrode-based Brain Stimulation in Humans

NCT07630545Phase 1RecruitingPrimary

A Phase I Study in Healthy Volunteers and Parkinson's Disease (PD) Patients.

NCT07340073Phase 1Not Yet RecruitingPrimary

Coordinated Reset Deep Brain Stimulation for Parkinson's Disease

NCT07806019Phase 4Not Yet RecruitingPrimary

Metformin in Parkinson's Disease: Safety and Efficacy

NCT07808346Not ApplicableActive Not RecruitingPrimary

Investigating Basal Ganglia-Cortical Physiology During Sleep and Its Modulation by Adaptive Deep Brain Stimulation in Parkinson Disease

NCT07777419Not ApplicableRecruitingPrimary

Impact of Subthalamic Nucleus Deep Brain Stimulation on COGnitive and PSYchiatric Symptoms in Parkinson's Disease

NCT07798700Recruiting

Biofluid Research on Age-Related or Inherited Neurodegeneration

NCT07604116Phase 1Recruiting

A Study to Evaluate Satety, Tolerability, Biodistribution, Radiation Dosimetry, and Pharmacokinetics of SST001 in Healthy Volunteers, Patients With PD and Patients With MSA

NCT06993571Not ApplicableRecruitingPrimary

Cerebellar Transcranial Alternating Current Stimulation (tACS) to Modulate Parkinson's Disease Tremor

NCT07267065Phase 1Not Yet RecruitingPrimary

AAV2-hAADC for Parkinson's Disease (PDCS-01)

NCT07790744Recruiting

A Comprehensive, Multimodal Characterization of Prodromal PD in Subjects With RBD

NCT07705373Not ApplicableRecruitingPrimary

A Novel Digital Music-based Autonomous Personalized Walking Intervention to Improve Gait and Walking Automaticity in Parkinson Disease

NCT07774312Not ApplicableRecruitingPrimary

STN-tTIS With Different Intervention Intervals Versus Standard Medical Treatment for Parkinson's Disease

Scroll to load more

Research Network

Activity Timeline